Showing results (81-90 of 147) with videos related to
Sort By:
Pageof 15
Journal of Cachexia, Sarcopenia and Muscle|March 18, 2021
Advanced cancer is also a heart failure syndrome: a hypothesisMarkus S Anker, Ana Pardo Sanz, José L Zamorano, et al.TH Open : Companion Journal to Thrombosis and Haemostasis|May 29, 2020
Assessing Full Benefit of Rivaroxaban Prophylaxis in High-Risk Ambulatory Patients with Cancer: Thromboembolic Events in the Randomized CASSINI TrialAlok A Khorana, Mairéad G McNamara, Ajay K Kakkar, et al.Surgery|June 23, 2009
Nonresponse to pre-operative chemotherapy does not preclude long-term survival after liver resection in patients with colorectal liver metastasesUlf P Neumann, Armin Thelen, Christoph Röcken, et al.European Journal of Heart Failure|December 3, 2016
Resting heart rate is an independent predictor of death in patients with colorectal, pancreatic, and non-small cell lung cancer: results of a prospective cardiovascular long-term studyMarkus S Anker, Nicole Ebner, Bert Hildebrandt, et al.Hamostaseologie|July 15, 2024
Antithrombotic Therapy in Cancer Patients with Cardiovascular Diseases: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society for Thrombosis and Hemostasis Research (GTH e.V.)Stefani Parmentier, Steffen Koschmieder, Larissa Henze, et al.European Journal of Heart Failure|November 28, 2020
Advanced cancer is also a heart failure syndrome: a hypothesisMarkus S Anker, Ana Pardo Sanz, José L Zamorano, et al.Research and Practice in Thrombosis and Haemostasis|July 26, 2021
Rivaroxaban thromboprophylaxis for gastric/gastroesophageal junction tumors versus other tumors: A post hoc analysis of the randomized CASSINI trialJodi V Mones, Michael B Streiff, Alok A Khorana, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapyBeate Rau, Isrid Sturm, Hermann Lage, et al.Pancreas|May 2, 2015
Cytoreductive Surgery for Pancreatic Cancer Improves Overall Outcome of Gemcitabine-Based ChemotherapyMarcus Bahra, Johann Pratschke, Fritz Klein, et al.European Journal of Cancer (Oxford, England : 1990)|May 3, 2021
Impact of completeness of adjuvant gemcitabine, relapse pattern, and subsequent therapy on outcome of patients with resected pancreatic ductal adenocarcinoma - A pooled analysis of CONKO-001, CONKO-005, and CONKO-006 trialsAnnika Kurreck, Johanna Weckwerth, Dominik P Modest, et al.Pageof 15